About Galvanize
Galvanize is a biomedical platform company operating at the convergence of engineering, biology, and healthcare delivery, aiming to deliver life-changing solutions to patients and their doctors.
We create Pulsed Electric Field technologies capable of targeting cells involved in disease processes, in ways unparalleled to other devices or drugs.
We study our technologies in well designed clinical trials to ensure safety and efficacy.
We partner with doctors and healthcare systems so that patients can access our therapies.
We are dedicated to operating with integrity and in full compliance with applicable health care laws and regulations. Concerns may be reported anonymously through our hotline at 1-833-214-7236, emailed to reports@lighthouse-services.com/galvantizetx.com with Galvanize in the subject line, or submitted online at www.lighthouse-services.com/galvanizetx.
Our California Compliance Declaration is available in accordance with California Health and Safety Code Section 119402.
Galvanize Leadership
Board of Directors
Investors
Galvanize was created and incubated by ATP (Apple Tree Partners).
Other investors in Galvanize include Intuitive Surgical, Gilmartin Capital, and T. Rowe Price; Sofinnova Partners, Norwest Venture Partners, Elevage Medical Technologies, Ally Bridge Group, Perceptive Xontogeny Venture Fund, Janus Henderson Investors and Longaeva.